Evidence-Based Guidelines Issued by ASTRO Support Sensus Healthcare’s SRT Technology as the First-Line Alternative to Surgery for Treating Non-Melanoma Skin Cancer

    NEXT STORY
    PDS Biotech Collaborator Granted NIAID Award to Accelerate Development of Versamune®-Based Universal Influenza Vaccine
    PREV STORY
    Worldwide Outlook on the Medical and Lab Refrigerator Industry to 2027 – Featuring Felix Storch, Follett & Helmer Scientific Among Others
    Subscribe to PM360
    Print Subscription
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Novartis Phase III data on new inhaled dual combination QMF149 show significant improvement across key asthma outcomes versus monotherapy

    author_avatar
    NASDAQ Market News

    CorMedix Inc. to Present at the H.C. Wainwright 21st Annual Global Investment Conference

    author_avatar
    NASDAQ Market News

    Cellectar Biosciences Announces $2 Million NCI SBIR Contract for a Phase 2 Clinical Study

    MADISON, Wis., Aug. 03, 2016 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq:CLRB) ("the company"), ...

    author_avatar
    NASDAQ Market News